Vinva Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.4M Buy
487,011
+283,432
+139% +$22.9M 0.26% 93
2026
Q1
$17.5M Sell
203,579
-7,296
-3% -$699K 0.22% 113
2025
Q4
$20.4M Buy
210,875
+70,075
+50% +$6.81M 0.25% 103
2025
Q3
$13.2M Buy
140,800
+27,429
+24% +$2.52M 0.26% 96
2025
Q2
$9.75M Buy
113,371
+34,663
+44% +$2.94M 0.25% 101
2025
Q1
$6.9M Buy
78,708
+1,769
+2% +$158K 0.27% 91
2024
Q4
$6.13M Buy
76,939
+10,736
+16% +$929K 0.23% 102
2024
Q3
$5.91M Buy
66,203
+6,757
+11% +$568K 0.25% 102
2024
Q2
$4.72M Buy
59,446
+8,625
+17% +$707K 0.24% 105
2024
Q1
$4.43M Buy
50,821
+4,437
+10% +$379K 0.25% 104
2023
Q4
$3.84M Buy
46,384
+7,074
+18% +$539K 0.26% 93
2023
Q3
$3.09M Buy
39,310
+271
+0.7% +$22.7K 0.29% 83
2023
Q2
$3.39M Sell
39,039
-5,568
-12% -$479K 0.29% 83
2023
Q1
$3.53M Buy
+44,607
New +$3.64M 0.29% 90

Other funds holding MDT

Vinva Investment Management's MDT Position: Q2 2026 in Review

Vinva Investment Management increased its Medtronic (MDT) stake by 139% in Q2 2026, buying an estimated $22.9M and bringing the position to 487,011 shares worth $39.4M. The position accounts for 0.26% of the portfolio, ranked #93.

Vinva Investment Management first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vinva Investment Management held 487,011 shares of Medtronic worth $39.4M as of Q2 2026.
  • Vinva Investment Management bought 283,432 Medtronic shares in Q2 2026, an estimated $22.9M.
  • Medtronic made up 0.26% of Vinva Investment Management's portfolio in Q2 2026, its #93 holding.
  • Vinva Investment Management first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.